← Back to Search

Experimental Group for Lung Cancer

N/A

Recruiting

Led By Jamie Studts, PhD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

"This trial aims to see if the Engaged Approach to Lung Cancer Screening is practical and well-received in different lung cancer screening programs in Colorado and the US."

Who is the study for?

This trial is for individuals who are eligible for lung cancer screening. Specific eligibility details, such as age range or risk factors like smoking history, aren't provided here. The study aims to include a diverse group from various regions in Colorado and the US.Check my eligibility

What is being tested?

The study is testing the 'Engaged Approach to Lung Cancer Screening' (EA-LCS), which likely involves strategies to improve patient participation and effectiveness of lung cancer screenings across different locations.See study design

What are the potential side effects?

Since this trial focuses on a screening approach rather than a medical treatment, traditional side effects are not applicable. However, there may be psychological impacts or discomfort related to the screening process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of participants who would describe the framework as workable

Percentage of the intervention group who would like to continue the EA-LCS framework

Percentage of the intervention group who would recommend the EA-LCS framework to other programs

Secondary outcome measures

Evaluate the intervention acceptability by Acceptability of Intervention Measure (AIM)

Evaluate the intervention appropriateness by Intervention Appropriateness Measure (IAM)

Evaluate the intervention feasibility by Feasibility of Intervention Measure (FIM)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental GroupExperimental Treatment1 Intervention

Sites randomized to use the EA-LCS materials will be given password-protected access to the program/toolkit web portal and encouraged to use any materials that fit the normal flow of clinic procedures. Materials available include both staff-facing and LCS candidate-facing materials.

Group II: Control GroupActive Control1 Intervention

Sites in the control condition will be asked to complete appropriate/relevant surveys and interviews with minor modifications as needed and use the same Electronic Health Record Data Abstraction process.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,738 Previous Clinical Trials

2,149,486 Total Patients Enrolled

Bristol-Myers SquibbIndustry Sponsor

2,641 Previous Clinical Trials

4,130,024 Total Patients Enrolled

Jamie Studts, PhDPrincipal InvestigatorUniversity of Colorado, Denver

1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this clinical trial currently open?

"As per clinicaltrials.gov, this study is currently in the patient recruitment phase. It was first listed on 3rd November 2024 and last modified on 21st March 2024."

Answered by AI

What is the current number of individuals who have been granted admission to participate in this clinical study?

"Indeed, data from clinicaltrials.gov confirms the ongoing recruitment of subjects for this investigation. The trial was first listed on March 11th, 2024 and last revised on March 21st, 2024. Enrollment is aimed at securing 40 participants from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing the Engaged Approach to Lung Cancer Screening

2024. "Testing the Engaged Approach to Lung Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06327074.

All > Denver > Colorado Springs